Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept

被引:0
作者
Harris A. Ahmad
Joshua F. Baker
Philip G. Conaghan
Paul Emery
Thomas W. J. Huizinga
Yedid Elbez
Subhashis Banerjee
Mikkel Østergaard
机构
[1] Bristol Myers Squibb,Leeds Institute of Rheumatic and Musculoskeletal Medicine
[2] Philadelphia Veteran’s Administration Medical Center and the University of Pennsylvania,Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet and Department of Clinical Medicine
[3] University of Leeds and NIHR Leeds Biomedical Research Centre,undefined
[4] Leiden University Medical Center,undefined
[5] Deepscover,undefined
[6] University of Copenhagen,undefined
来源
Arthritis Research & Therapy | / 24卷
关键词
Rheumatoid arthritis; Disease-modifying antirheumatic drugs (DMARDs); Magnetic resonance imaging (MRI); Abatacept; Flare;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 199 条
[1]  
Smolen JS(2018)Rheumatoid arthritis Nat Rev Dis Primers 4 18001-2038
[2]  
Aletaha D(2016)Rheumatoid arthritis Lancet. 388 2023-26
[3]  
Barton A(2016)2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis Arthritis Care Res. 68 1-977
[4]  
Burmester GR(2017)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update Ann Rheum Dis. 76 960-959
[5]  
Emery P(2016)2016 update of the EULAR recommendations for the management of early arthritis Ann Rheum Dis. 76 948-15
[6]  
Firestein GS(2016)Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force Ann Rheum Dis. 75 3-1414
[7]  
Smolen J(2015)Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis Rheumatology (Oxford). 54 1408-1581
[8]  
Aletaha D(2016)Tapering and discontinuation of TNF-alpha blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission Arthritis Res Ther. 18 39-980
[9]  
McInnes I(2014)Prediction of relapse after discontinuation of biologic agents by ultrasonographic assessment in patients with rheumatoid arthritis in clinical remission: high predictive values of total gray-scale and power Doppler scores that represent residual synovial inflammation before discontinuation Arthritis Care Res (Hoboken). 66 1576-1974
[10]  
Singh JA(2017)A multi-biomarker score measuring disease activity in rheumatoid arthritis patients tapering adalimumab or etanercept: predictive value for clinical and radiographic outcomes Rheumatology (Oxford). 56 973-1974